A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Solid Tumors|Advanced or Metastatic Breast Cancer
Interventions: DRUG: Azacitidine (Vidaza)|DRUG: Nab-paclitaxel (Abraxane)
Sponsor: University of Utah
Collaborators: Celgene Corporation